EX-23.1 3 a08-14845_1ex23d1.htm EX-23.1

EXHIBIT 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) to be filed on or about May 21, 2008, and related Prospectus of Isis Pharmaceuticals, Inc. for the registration of 5,000,000 shares of its common stock and to the incorporation by reference therein of our reports dated March 11, 2008, with respect to the consolidated financial statements of Isis Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Isis Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2007, filed with the Securities and Exchange Commission.

 

 

 

/s/ ERNST & YOUNG LLP

 

 

San Diego, California

 

May 19, 2008